Thursday, 9 February 2017

Detailed Report on Global Chronic Idiopathic Constipation(CIC)Drugs Sales Market 2017

Global Chronic Idiopathic Constipation(CIC)Drugs Sales Market Report 2017 is a new market research publication announced by Reportstack. This report studies sales (consumption) of Chronic Idiopathic Constipation (CIC) Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering 
Actavis 
Chugai Pharmaceutical 
Ferring International Center S.A. 
Synergy Pharmaceuticals 
Pfizer 
GlaxoSmithKline 
Roche Holding AG 
Sanofi 
Bayer AG 
Salix Pharmaceuticals Ltd 
Sucampo Pharmaceuticals Inc 
Ironwood Pharmaceuticals 
Progenics Pharmaceuticals
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs in these regions, from 2011 to 2021 (forecast), like 
United States 
China 
Europe 
Japan 
Southeast Asia 
India 
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into 
Lubiprostone 
Linaclotide 
Others 
Split by applications, this report focuses on sales, market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs in each application, can be divided into 
Hospitals & Clinics 
Ambulatory Surgical Centres 
Long Term Care Centres 
Others
Snapshot of TOC with Companies Mentioned
9 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Analysis 
9.1 Actavis 
9.1.1 Company Basic Information, Manufacturing Base and Competitors 
9.1.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.1.2.1 Lubiprostone 
9.1.2.2 Linaclotide 
9.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.1.4 Main Business/Business Overview 
9.2 Chugai Pharmaceutical 
9.2.1 Company Basic Information, Manufacturing Base and Competitors 
9.2.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.2.2.1 Lubiprostone 
9.2.2.2 Linaclotide 
9.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.2.4 Main Business/Business Overview 
9.3 Ferring International Center S.A. 
9.3.1 Company Basic Information, Manufacturing Base and Competitors 
9.3.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.3.2.1 Lubiprostone 
9.3.2.2 Linaclotide 
9.3.3 Ferring International Center S.A. Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.3.4 Main Business/Business Overview 
9.4 Synergy Pharmaceuticals 
9.4.1 Company Basic Information, Manufacturing Base and Competitors 
9.4.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.4.2.1 Lubiprostone 
9.4.2.2 Linaclotide 
9.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.4.4 Main Business/Business Overview 
9.5 Pfizer 
9.5.1 Company Basic Information, Manufacturing Base and Competitors 
9.5.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.5.2.1 Lubiprostone 
9.5.2.2 Linaclotide 
9.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.5.4 Main Business/Business Overview 
9.6 GlaxoSmithKline 
9.6.1 Company Basic Information, Manufacturing Base and Competitors 
9.6.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.6.2.1 Lubiprostone 
9.6.2.2 Linaclotide 
9.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.6.4 Main Business/Business Overview 
9.7 Roche Holding AG 
9.7.1 Company Basic Information, Manufacturing Base and Competitors 
9.7.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.7.2.1 Lubiprostone 
9.7.2.2 Linaclotide 
9.7.3 Roche Holding AG Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.7.4 Main Business/Business Overview 
9.8 Sanofi 
9.8.1 Company Basic Information, Manufacturing Base and Competitors 
9.8.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.8.2.1 Lubiprostone 
9.8.2.2 Linaclotide 
9.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.8.4 Main Business/Business Overview 
9.9 Bayer AG 
9.9.1 Company Basic Information, Manufacturing Base and Competitors 
9.9.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.9.2.1 Lubiprostone 
9.9.2.2 Linaclotide 
9.9.3 Bayer AG Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.9.4 Main Business/Business Overview 
9.10 Salix Pharmaceuticals Ltd 
9.10.1 Company Basic Information, Manufacturing Base and Competitors 
9.10.2 Chronic Idiopathic Constipation (CIC) Drugs Product Type, Application and Specification 
9.10.2.1 Lubiprostone 
9.10.2.2 Linaclotide 
9.10.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017) 
9.10.4 Main Business/Business Overview 
9.11 Sucampo Pharmaceuticals Inc 
9.12 Ironwood Pharmaceuticals 
9.13 Progenics Pharmaceuticals
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)